Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
26 Feb 2014 Selenium and Vitamin E Supplementation over Recommended Dietary Intake May Raise Prostate Cancer Risk Genitourinary cancers - Cancer prevention
25 Feb 2014 Promising Results of GOG Study with Bevacizumab for Advanced Cervical Cancer Gynaecologic malignancies - Anticancer agents & Biologic therapy
24 Feb 2014 Bevacizumab Fails to Improve Overall Survival in First-Line Treatment for Glioblastoma Central nervous system malignancies - Anticancer agents & Biologic therapy
17 Feb 2014 How to Reset Strategies to Maximise the Potential of PI3K/AKT/mTOR Inhibitors in Cancer Therapy Anticancer agents & Biologic therapy
13 Feb 2014 FDA Approves Ibrutinib for Chronic Lymphocytic Leukaemia Haematologic malignancies - Anticancer agents & Biologic therapy
12 Feb 2014 Who are the Originators of Innovative Medicines in the EU? Bioethics, legal and economic issues - Anticancer agents & Biologic therapy
06 Feb 2014 World Cancer Report 2014 Cancer prevention
05 Feb 2014 SWITCH Study of Efficacy and Safety of Sorafenib/Sunitinib vs. Sunitinib/Sorafenib in the Treatment of mRCC Genitourinary cancers - Anticancer agents & Biologic therapy
04 Feb 2014 Enzalutamide in Chemotherapy-Naive mCRPC Genitourinary cancers - Anticancer agents & Biologic therapy
04 Feb 2014 ESMO Supports World Cancer Day 2014 Bioethics, legal and economic issues
03 Feb 2014 Analysis of Somatic Point Mutations in Exome Sequences Translational research
29 Jan 2014 Analysis of Role of Different Genetic Variants Involved in Lynch Syndrome Cancer prevention
29 Jan 2014 European Medicines Agency Recommended Marketing Authorisation for 16 Medicines for the Treatment of Cancer in 2013 Anticancer agents & Biologic therapy
27 Jan 2014 European Medicines Agency Recommends Refusal of the Marketing Authorisation for Masitinib Gastrointestinal cancers - Anticancer agents & Biologic therapy
23 Jan 2014 Risk/Benefit Ratio of New Immunotherapy Strategies Immuno-oncology